SB220025

DB04338ExperimentalSmall molecule

SB220025: Overview.

Mechanism: Pharmacologically active on Mitogen-activated protein kinase 14 and Mitogen-activated protein kinase 1
Curator reviewed
Formula / weight: C₁₈H₁₉FN₆ · 338.3821 g/mol (avg)
Code names: SB220025

Resolves to

Compound

Structure

InChIKeyVSPFURGQAYMVAN-UHFFFAOYSA-NSMILESNC1=NC=CC(=N1)C1=C(N=CN1C1CCNCC1)C1=CC=C(F)C=C1

Targets

What you can answer from here — as of September 16, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with SB220025, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.